JanOne Inc. (NASDAQ:JAN), a company focused on finding treatments for conditions that cause severe pain and bringing to market drugs and therapies with non-addictive pain-relieving properties, has named Amol Soin, MD as its new chief medical officer, it was reported on Tuesday.

In the new role as chief medical officer, Dr Soin will guide the company's drug development activities, manage clinical research, set patient safety standards, and ensure regulatory compliance. In addition, Dr Soin will play an integral role in establishing collaborations and drug candidate selection as the company expands its range.

Dr Soin received his undergraduate degree from University of Akron, his MBA from University of Tennessee, his MD from Northeastern Ohio Universities College of Medicine, his master's in science from Brown University and also has studied at Dartmouth College. He is board certified in anaesthesiology and pain medicine and a fellow of interventional pain management at the World Institute of Pain, and he served as a pain management fellow at the Cleveland Clinic. He is the founder and chairman of the Ohio Pain Clinic. He has also held several prestigious positions including president of the Ohio Society of Interventional Pain Physicians, president of the American Society of Interventional Pain Physicians Foundation, president of the Society of Interventional Pain Management Surgery Centers and president – elect of TriState Pain Society. He was appointed by Governor Kasich to the Ohio Medical Board in 2012 to two five year terms and has served as the Ohio Medical Board's president where he was instrumental in passing state-wide rules and guidelines to help the opioid crisis.